1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

2.             China Transmucosal Drug Delivery Systems Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             China Transmucosal Drug Delivery Systems Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1       China PEST Analysis

4.3       Expert Opinions

4.4       Epidemiology Data

4.5       Regulatory Scenario for Methotryxate in China

4.6       Pricing Analysis

5.             Transmucosal Drug Delivery Systems Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1       Rising Prevalence of Chronic Diseases

5.1.2       Advantages of Transmucosal Drug Delivery

5.2       Key Market Restraint

5.2.1       High Cost Involved in the Development of Drug Delivery Devices

5.3       Key Market Opportunity

5.3.1       Increasing Preference Towards Self-Administration and Home Care

5.4       Future Trend

5.4.1       Research and Development in Transmucosal Drug Delivery

5.5       Impact Analysis

6.             China Transmucosal Drug Delivery Systems Market – China Market Analysis

6.1       Overview

6.2       China Transmucosal Drug Delivery Systems Market – Revenue Forecasts and Analysis – 2018- 2027

7.             China Transmucosal Drug Delivery Systems Market Analysis– by Route of Administration

7.1       Overview

7.2       China Transmucosal Drug Delivery Systems Market, By Route of Administration 2018 & 2027 (%)

7.3       Oral Market

7.3.1       Overview

7.3.2       China Oral Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       Vaginal Market

7.4.1       Overview

7.4.2       China Vaginal Market Revenue and Forecasts to 2027 (US$ Mn)

7.5       Nasal Market

7.5.1       Overview

7.5.2       China Nasal Market Revenue and Forecasts to 2027 (US$ Mn)

7.6       Urethral/Rectal Market

7.6.1       Overview

7.6.2       China Urethral/Rectal Market Revenue and Forecasts to 2027 (US$ Mn)

8.             China Transmucosal Drug Delivery Systems Market Analysis– by Age Group

8.1       Overview

8.2       China Transmucosal Drug Delivery Systems Market, By Age Group 2018 & 2027 (%)

8.3       Adults Market

8.3.1       Overview

8.3.2       China Adults Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Pediatrics Market

8.4.1       Overview

8.4.2       China Pediatrics Market Revenue and Forecasts to 2027 (US$ Mn)

9.             China Transmucosal Drug Delivery Systems Market Analysis– by End User

9.1.1       Overview

9.1.2       China Transmucosal Drug Delivery Systems Market, By End User 2018 & 2027 (%)

9.1.3       Hospitals Market

9.1.4       Overview

9.1.5       China Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6       Clinics Market

9.1.6.1    Overview

9.1.6.2    China Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7       Others Market

9.1.7.1    Overview

9.1.7.2    China Others Market Revenue and Forecasts to 2027 (US$ Mn)

10.          Transmucosal Drug Delivery Systems Market – Industry Landscape

10.1    Overview

10.2    Growth Strategies done by the companies in the Market, (%)

10.3    Organic Developments

10.3.1    Overview

10.4    Inorganic developments

10.4.1    Overview

11.          Transmucosal Drug Delivery Systems Market–Key Company Profiles

11.1    3M

11.1.1    Key Facts

11.1.2    Business Description

11.1.3    Financial Overview

11.1.4    Product Portfolio

11.1.5    SWOT Analysis

11.1.6    Key Developments

11.2   Acrux Limited

11.2.1    Key Facts

11.2.2    Business Description

11.2.3    Products and Services

11.2.4    Financial Overview

11.2.5    SWOT Analysis

11.2.6    Key Developments

11.3    GW Pharmaceuticals plc.

11.3.1    Key Facts

11.3.2    Business Description

11.3.3    Financial Information

11.3.4    Product Portfolio

11.3.5    SWOT Analysis

11.3.6    Key Developments

11.4    INTELGENX CORP

11.4.1    Key Facts

11.4.2    Business Description

11.4.3    Financial Information

11.4.4    Product Portfolio

11.4.5    SWOT Analysis

11.4.6    Key Developments

11.5    Mylan N.V.

11.5.1    Key Facts

11.5.2    Business Description

11.5.3    Products and Services

11.5.4    Financial Overview

11.5.5    SWOT Analysis

11.5.6    Key Developments

11.6    Novartis AG

11.6.1    Key Facts

11.6.2    Business Description

11.6.3    Financial Information

11.6.4    Product Portfolio

11.6.5    SWOT Analysis

11.6.6    Key Developments

11.7    Reckitt Benckiser Group plc.

11.7.1    Key Facts

11.7.2    Business Description

11.7.3    Financial Overview

11.7.4    Product Portfolio

11.7.5    SWOT Analysis

11.7.6    Key Developments

11.8    Teva Pharmaceutical Industries Ltd

11.8.1    Key Facts

11.8.2    Business Description

11.8.3    Financial Overview

11.8.4    Product Portfolio

11.8.5    SWOT Analysis

11.8.6    Key Developments

11.9    UCB S.A.

11.9.1    Key Facts

11.9.2    Business Description

11.9.3    Products and Services

11.9.4    Financial Overview

11.9.5    SWOT Analysis

11.9.6    Key Developments

11.10  West Pharmaceutical Services, Inc.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Financial Overview

11.10.4 Product Portfolio

11.10.5 SWOT Analysis

11.10.6 Key Developments

12.          Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms

LIST OF TABLES

Table 1.            Number of new cases in China (2018)

Table 2.            Prevalence of Comorbidities in China

Table 3.            Organic Developments Done By Companies

Table 4.            Inorganic developments done by Companies

Table 5.            Glossary of Terms, Transmucosal Drug Delivery Systems Market

LIST OF FIGURES

Figure 1.          Transmucosal Drug Delivery Systems Market Segmentation

Figure 2.          China Transmucosal Drug Delivery Systems Market Overview

Figure 3.          Oral Segment Held Largest Share Of The Route of Administration Segment In Transmucosal Drug Delivery Systems Market

Figure 4.          China Transmucosal Drug Delivery Systems Market, Industry Landscape

Figure 5.          China PEST Analysis

Figure 6.          Number of new cases China (2018)

Figure 7.          Impact Analysis of Drivers and Restraint Pertaining to Transmucosal Drug Delivery Systems Market

Figure 8.          China Transmucosal Drug Delivery Systems Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 9.          China Transmucosal Drug Delivery Systems Market, by Route of Administration 2018 & 2027 (%)

Figure 10.       China Oral Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.       China Vaginal Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.       China Nasal Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.       China Urethral/Rectal Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.       China Transmucosal Drug Delivery Systems Market, by Age Group 2018 & 2027 (%)

Figure 15.       China Adults Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.       China Pediatrics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.       China Transmucosal Drug Delivery Systems Market, by End User 2018 & 2027 (%)

Figure 18.       China Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.       China Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.       China Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       Growth Strategies done by the companies in the Market, (%)